Suppr超能文献

实时 PCR 检测 ZAP-70 mRNA 的表达水平是慢性淋巴细胞白血病的一个预后因素。

Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia.

机构信息

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.

出版信息

J Cancer Res Clin Oncol. 2012 Jun;138(6):1011-7. doi: 10.1007/s00432-012-1177-3. Epub 2012 Feb 24.

Abstract

BACKGROUND

Chronic lymphocytic leukemia (CLL) is heterogeneous with respect to prognosis and clinical outcome. Mutational status of immunoglobulin heavy chain variable region (IGHV) appears to be a particularly strong prognostic marker, but it is difficult to perform in a routine clinical laboratory. ζ-chain-associated protein kinase 70 kDa (ZAP-70) protein detected by flow cytometry is a strong surrogate marker of IGHV mutational status; however, it suffers from the lack of standardization.

METHODS

We investigated whether ZAP-70 mRNA expression level can be a prognostic factor in CLL. Real-time quantitative polymerase chain reaction was used to analyze ZAP-70 mRNA expression from 102 CLL patients.

RESULTS

The expression of ZAP-70 mRNA was significantly associated with Binet stage (P < 0.001), lactate dehydrogenase (P = 0.003), ZAP-70 protein (P = 0.018), IGHV mutational status (P = 0.038), and cytogenetic abnormality of del(17p13) or del(11q22.3) (P = 0.037) in CLL patients. According to receiver operating characteristic curve analysis for ZAP-70 mRNA and ZAP-70 protein, positive ZAP-70 mRNA (P = 0.006) was an adverse factor in determining the treatment free survival (TFS). In a multivariate Cox analysis of TFS, ZAP-70 mRNA is not ideal as an independent prognostic factor. However, ZAP-70 mRNA was statistically significant in predicting treatment response.

CONCLUSION

This study demonstrated the value of determination of ZAP-70 mRNA in providing useful prognostic information in CLL patients. However, ZAP-70 mRNA is not an independent prognostic factor.

摘要

背景

慢性淋巴细胞白血病(CLL)在预后和临床结果方面存在异质性。免疫球蛋白重链可变区(IGHV)的突变状态似乎是一个特别强的预后标志物,但在常规临床实验室中难以进行。通过流式细胞术检测的 ζ 链相关蛋白激酶 70 kDa(ZAP-70)蛋白是 IGHV 突变状态的强有力替代标志物;然而,它缺乏标准化。

方法

我们研究了 ZAP-70 mRNA 表达水平是否可以成为 CLL 的预后因素。使用实时定量聚合酶链反应分析了 102 例 CLL 患者的 ZAP-70 mRNA 表达。

结果

ZAP-70 mRNA 的表达与 Binet 分期(P < 0.001)、乳酸脱氢酶(P = 0.003)、ZAP-70 蛋白(P = 0.018)、IGHV 突变状态(P = 0.038)和染色体异常 del(17p13) 或 del(11q22.3)(P = 0.037)显著相关。根据 ZAP-70 mRNA 和 ZAP-70 蛋白的受试者工作特征曲线分析,阳性 ZAP-70 mRNA(P = 0.006)是确定无治疗生存(TFS)的不利因素。在 TFS 的多变量 Cox 分析中,ZAP-70 mRNA 作为独立预后因素并不理想。然而,ZAP-70 mRNA 在预测治疗反应方面具有统计学意义。

结论

本研究表明,测定 ZAP-70 mRNA 在提供 CLL 患者有用的预后信息方面具有价值。然而,ZAP-70 mRNA 不是独立的预后因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验